PMID- 14983406 OWN - NLM STAT- MEDLINE DCOM- 20040923 LR - 20090219 IS - 0018-5043 (Print) IS - 0018-5043 (Linking) VI - 36 IP - 1 DP - 2004 Jan TI - Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. PG - 44-7 AB - OBJECTIVE: Cytokines play an important role in autoimmune thyroid diseases, and serum levels may reflect the activity of the immune process. This is particularly interesting in Graves' ophthalmopathy, where a reliable serum activity marker is warranted. Interleukin-18 (IL-18) is a potent Th1 cytokine, known to induce interferon (IFN)-gamma and the aim of this study was to evaluate serum IL-18 levels in Graves' ophthalmopathy. METHODS: Serum IL-18 was measured by ELISA in 52 patients with untreated Graves' ophthalmopathy (who all had been rendered euthyroid with antithyroid drugs), 52 healthy controls matched for sex, age, and smoking habits, and 15 euthyroid patients who had been treated for Graves' hyperthyroidism and ophthalmopathy in the past. RESULTS: Serum IL-18 (median values in pg/ml with range) levels did not differ between the untreated Graves' ophthalmopathy patients-226 (61-704) pg/ml, matched healthy controls-194 (17-802) pg/ml, and Graves' ophthalmopathy patients treated in the past-146 (0-608) pg/ml. No correlation was observed between serum IL-18 levels and thyroid function or antithyroid antibodies. There was no correlation between serum IL-18 levels and smoking habits. CONCLUSION: We conclude that Graves' ophthalmopathy does not affect serum IL-18. FAU - Wakelkamp, I M M J AU - Wakelkamp IM AD - Department of Endocrinology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. I.M.M.J.Wakelkamp@amc.uva.nl FAU - Prummel, M F AU - Prummel MF FAU - Wiersinga, W M AU - Wiersinga WM LA - eng PT - Journal Article PL - Germany TA - Horm Metab Res JT - Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme JID - 0177722 RN - 0 (Antithyroid Agents) RN - 0 (Autoantibodies) RN - 0 (Immunoglobulins, Thyroid-Stimulating) RN - 0 (Interleukin-18) RN - 0 (Receptors, Thyrotropin) RN - 0 (thyrotropin-binding inhibitory immunoglobulin) SB - IM MH - Adult MH - Antithyroid Agents/therapeutic use MH - Autoantibodies/blood MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Graves Disease/*blood/drug therapy MH - Humans MH - Immunoglobulins, Thyroid-Stimulating MH - Interleukin-18/*blood MH - Male MH - Middle Aged MH - Receptors, Thyrotropin/blood MH - Smoking/blood EDAT- 2004/02/26 05:00 MHDA- 2004/09/24 05:00 CRDT- 2004/02/26 05:00 PHST- 2004/02/26 05:00 [pubmed] PHST- 2004/09/24 05:00 [medline] PHST- 2004/02/26 05:00 [entrez] AID - 10.1055/s-2004-814102 [doi] PST - ppublish SO - Horm Metab Res. 2004 Jan;36(1):44-7. doi: 10.1055/s-2004-814102.